What is Cyberknife? Cyberknife is a form of stereotactic body radiation therapy (SBRT) and robotic-assisted radiosurgery (not actual surgery) that utilizes a computerized robot to automatically deliver high doses of radiation to the prostate gland. Fiducials are implanted into the body so that the Cyberknife machine can adjust to movement during each treatment.
Read MoreA new study from Australia suggests that robotic-assisted laparoscopic radical prostatectomy is more effective at preserving erectile function and urinary continence than a laparoscopic radical prostatectomy for treating localized prostate cancer. The study was recently published as a meta-analysis in Urologia Internationalis. The study was conducted by researchers at Monash University in Melbourne, Australia. It involved two randomized controlled trials and included a total of 232 patients in which each of their surgical approaches were compared.
Read MoreProstate cancer is one of the most common types of cancer in men. It starts in the prostate gland, which is a small walnut-shaped gland that is responsible for the production of seminal fluid. Prostate cancer is often a slow growing disease, but in some cases and depending on certain risk factors, it can be an aggressive disease and spread rather quickly.
Read MoreThe U.S. Preventive Services Task Force recommends against PSA (prostate specific antigen) screening for prostate cancer. The task force currently gives PSA screening a grade D, meaning that there is moderate or high certainty that the PSA test has no benefit or that the harms outweigh the benefits. This recommendation was first issued in 2011.
Read MoreWho's at risk for prostate cancer? Knowing your risk factors such as lifestyle habits and family history can save your life. Knowledge is power. Here's what men and women need to know.
Read MoreA new study from Duke University Medical Center published in the journal, BMC Medicine, showed that what you eat can influence the risk of prostate cancer. Here's what men need to know.
Read MoreA multi-center study by New York Presbyterian/Columbia University Medical Center found a urine test can determine if a patient has high-grade prostate cancer with 92% accuracy. The findings were presented at the AUA 2015 Annual Meeting. This study could present a breakthrough in how doctors screen for prostate cancer.
Read MoreWhy is this important? Because prostate cancer is to men as breast cancer is to women. And just as with any other cancer, an early understanding of your risk factors and how to potentially reduce them is tremendously valuable. We explore.
Read More
The treatment options for prostate cancer can vary depending on a number of factors. These factors also affect the prognosis of the disease. The most important factor when determining which treatment option is best is the stage of the prostate cancer.
Read MoreWe've seen a six-fold increase in younger men getting prostate cancer. And if it occurs in younger men, the tumor is more likely to be growing at a rapid rate. Here's what they need to know.
Read MoreNew study shows there may be a significant link between baldness and a higher risk of prostate cancer. Men, here's what you need to know.
Read MoreNew research has emerged these past few weeks on prostate cancer diagnosis, treatment and its genetic root. There's a big debate in how prostate cancer should be treated in older verses younger men. Now, a new study is showing where the gaps are and in particular when we find aggressive prostate cancer, how it should be treated.
Read More
